Fidelis Pharmaceuticals
Fidelis Pharmaceuticals: US-based provider of unique veterinary formulations, serving global needs.
Founded
2016Fidelis Pharmaceuticals: US-based provider of unique veterinary formulations, serving global needs.
Fidelis Pharmaceuticals is a U.S.-based company specializing in the acquisition, development, and marketing of unique pharmaceutical formulations tailored to specialized veterinary needs. Headquartered in North Brunswick, New Jersey, Fidelis focuses on providing innovative drug delivery technology and long-lasting pain management solutions for animals. The company operates globally from the Northeast pharmaceutical corridor, aiming to address critical gaps in veterinary medicine.
Fidelis Pharmaceuticals has established itself as a leader in veterinary pain management through its extensive pipeline of innovative products. The company's expertise in drug delivery technology has enabled it to develop effective and long-lasting formulations that significantly improve animal health and welfare. Fidelis continues to make a substantial impact in the veterinary pharmaceutical industry, driven by its commitment to addressing specialized veterinary needs worldwide.
Companies similar to Fidelis Pharmaceuticals include Wilmington Pharmaceuticals, Companion Pharma, US Specialty Formulations and Elite Pharmaceuticals.
Fidelis Pharmaceuticals was founded in 2016.
Fidelis Pharmaceuticals' headquarters is located in North Brunswick, NJ, US.
Fidelis Pharmaceuticals' most recent funding round was for $5.1M (USD) in July 2021.
As of Jul 21, 2021, Fidelis Pharmaceuticals has disclosed funding of $5.1M (USD). Undisclosed round amounts are excluded.
Fidelis Pharmaceuticals has 6 employees as of Feb 5, 2024.
Elite Pharmaceuticals
elitepharma.com
